Peptides for aesthetics: separating fitness hype from clinical evidence

What did @flynwyethfit actually say?

The creator recommends three peptides for aesthetic improvement: a GLP-1 receptor agonist he calls "run a true tide" (almost certainly semaglutide or tirzepatide), GHK-Cu for skin and collagen, and Melanotan I or II for tanning. His framing is blunt: fat loss makes your face look better, GHK "clears up your skin a little bit," and Melanotan "just makes you tan." He personally prefers MT2 because it "works a little faster," while acknowledging side effects including libido changes and appetite suppression.

To his credit, he keeps the claims relatively modest. He says peptides make you look "a little tighter" and "a little bit" better, not that they are miracle transformations. That restraint is unusual for this corner of TikTok. But modest language does not make every claim accurate, and the legal and safety picture around these compounds is more complicated than a 60-second video can capture.

Does the science back this up?

The science is genuinely mixed, and depends heavily on which compound you are discussing. GLP-1 agonists have the strongest clinical data. GHK-Cu has real but preliminary evidence. Melanotan II has the weakest legitimate research and the most serious unresolved safety questions.

On fat loss: semaglutide and tirzepatide are FDA-approved medications with robust randomized controlled trial data. Wilding et al. (2021, NEJM) showed semaglutide produced roughly 15% body weight reduction versus placebo. Jastreboff et al. (2022, NEJM) showed tirzepatide produced up to 22.5% weight loss. The "effortless" framing is oversimplified but the fat loss effect is real and well-documented.

On GHK-Cu: Pickart and Margolina (2018, Frontiers in Aging Neuroscience) reviewed decades of evidence showing GHK-Cu stimulates collagen synthesis and has antioxidant properties in cell and animal models. Human skin studies are smaller and shorter in duration. The collagen claim is plausible. The "clears up your skin" claim is less established in controlled trials.

On Melanotan II: MT2 activates melanocortin receptors and does produce tanning. But it is not FDA-approved, has no large-scale safety trials in humans, and published case reports document serious adverse effects including changes in existing moles and spontaneous erections. The European Medicines Agency has warned against its use.

What did they get wrong (or right)?

He got the GLP-1 fat loss story roughly right. The compounds work, they are clinically validated, and the body composition effects on appearance are real. Full credit there, though calling it "effortless" ignores side effect profiles that include nausea, GI distress, and potential muscle loss without adequate protein intake.

The GHK-Cu collagen claim is mostly accurate but overstated. Human topical data exists, for example Leyden et al. (2018) showed GHK-Cu peptide cream improved skin laxity in a randomized trial, but injectable GHK-Cu data in humans is sparse. Saying it definitively "boosts collagen production" as a systemic injectable is ahead of the current evidence.

The Melanotan framing is the most problematic. Saying MT2 "just makes you tan" skips past the fact that this compound has no regulatory approval anywhere for human cosmetic use, has documented risks around melanocyte activation in existing nevi, and the side effects he mentions, libido spike and appetite suppression, are pharmacological effects from a non-selective melanocortin agonist, not minor inconveniences. Framing MT1 as safer because "you don't get side effects" is also misleading. MT1 (afamelanotide) is FDA-approved for erythropoietic protoporphyria, not cosmetic tanning. Using it off-label for appearance is a very different context.

What should you actually know?

None of these compounds should be sourced without medical oversight, and one of them has active regulatory warnings. GLP-1 agonists like semaglutide and tirzepatide are prescription medications requiring evaluation by a licensed provider. GHK-Cu in injectable form is a compounded peptide without FDA approval for any indication. Melanotan II is not approved anywhere for human use and is classified as a research chemical in most jurisdictions.

The aesthetic framing of this video, better skin, better tan, more lean, is appealing and not entirely fictional. But the legal status of these compounds varies significantly, the risk profiles are not comparable, and sourcing them outside a regulated medical framework creates real harm potential. If you are interested in any of these compounds, the conversation starts with a licensed provider who can assess your individual health status, not a TikTok video with 52,000 views.

• GLP-1 agonists: strong clinical evidence, require prescription
• GHK-Cu: promising but preliminary human data, compounded injectable is unregulated
• Melanotan II: no approved human use, active safety warnings from EMA and others